Annual report pursuant to Section 13 and 15(d)

Equity-classified Warrants - Schedule of outstanding warrants (Details)

v3.21.1
Equity-classified Warrants - Schedule of outstanding warrants (Details) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Number of Shares    
Outstanding at December 31, 2019 240,100  
Granted 240,100  
Outstanding at December 31, 2020 240,100  
Weighted Average Exercise Price    
Outstanding at December 31, 2019 $ 11.00  
Granted 11.00  
Outstanding at December 31, 2020 $ 11.00  
Remaining Contractual Term (years)    
Outstanding at December 31, 2019 4 years 7 months 2 days 0 years
Granted 5 years  
Outstanding at December 31, 2020 4 years 7 months 2 days 0 years
Average Intrinsic Value    
Ending balance $ 6,012,104